Mediwound announces u.s. food and drug administration approval of nexobrid® for the treatment of pediatric patients with severe thermal burns

Approval helps solidify nexobrid's position in the u.s. as a safe and effective non-surgical burn treatment for all ages approval helps solidify nexobrid's position in the u.s. as a safe and effective non-surgical burn treatment for all ages
MDWD Ratings Summary
MDWD Quant Ranking